DC
Dinesh Chandak
About Dinesh Chandak
Data last updated:
Dinesh Chandak is a Director at Alfa Biomed India Private Limited (since 2021), Director at Generic Healthcare Private Limited (since 2024) and Director at Adna Foundation (since 2022), and holds 3 more current directorships. The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹135 Cr; the largest is Alfa Biomed India Private Limited at ₹117 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Alfa Biomed India Private Limited U74999PN2016FTC158316 | Director | 23 Aug 2021 | 2016 | ₹117 Cr (FY 2024) | Active |
 Generic Healthcare Private Limited U33110PN2010PTC136997 | Director | 16 Aug 2024 | 2010 | ₹17.92 Cr (FY 2025) | Active |
| Adna Foundation U85300PN2021NPL202345 | Director | 14 Jun 2022 | 2021 | ₹13,210 (FY 2025) | Active |
| Alfa Biomed Therapeutics Private Limited U21001PN2026PTC257617 | Director | 10 Jul 2026 | 2026 | Active | |
| Alfa Biomed International Private Limited U21001PN2026PTC257361 | Director | 04 Jul 2026 | 2026 | Active | |
| Sanzio Lifesciences Private Limited U21001PN2026PTC256779 | Director | 18 Jun 2026 | 2026 | Active |
Board colleagues of Dinesh Chandak
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aniket Bhalchandra Kulkarni | 09623717 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 2 more | Director |
| Anushka Abhijit Bora | 10258161 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 3 more | Director |
| Kiran Sukhdeo Malekar | 09021266 | Alfa Biomed India Private Limited | Director |
| Krishna Abhijit Bora | 10830754 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 4 more | Director |
| Rohit Balkrishna Kulkarni | Alfa Biomed India Private Limited | Company Secretary | |
| Sahadot Ali Mir | 11206866 | Alfa Biomed India Private Limited , Generic Healthcare Private Limited and 1 more | Director |
| Shirish Ramchandra Vankudre | 11950838 | Alfa Biomed International Private Limited | Additional Director |
| Sakti Pada Chakraborty | 00064434 | Sanzio Lifesciences Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dinesh Chandak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dinesh Chandak
Dinesh Chandak currently holds 6 directorships: Alfa Biomed India Private Limited (Director, since 23 Aug 2021, revenue ₹117 Cr (FY 2024)); Generic Healthcare Private Limited (Director, since 16 Aug 2024, revenue ₹17.92 Cr (FY 2025)); Adna Foundation (Director, since 14 Jun 2022, revenue ₹13,210 (FY 2025)); Alfa Biomed Therapeutics Private Limited (Director, since 10 Jul 2026); Alfa Biomed International Private Limited (Director, since 04 Jul 2026); and 1 more.
Dinesh Chandak was first appointed on 23 Aug 2021 as Director at Alfa Biomed India Private Limited. The most recent appointment on record is 10 Jul 2026 at Alfa Biomed Therapeutics Private Limited.
The 3 current companies of Dinesh Chandak that report revenue have a combined latest revenue of ₹135 Cr: Alfa Biomed India Private Limited ₹117 Cr (FY 2024); Generic Healthcare Private Limited ₹17.92 Cr (FY 2025); Adna Foundation ₹13,210 (FY 2025).
The current boards of Dinesh Chandak's companies include Aniket Bhalchandra Kulkarni (Alfa Biomed India Private Limited), Anushka Abhijit Bora (Alfa Biomed India Private Limited), Kiran Sukhdeo Malekar (Alfa Biomed India Private Limited), Krishna Abhijit Bora (Alfa Biomed India Private Limited), Rohit Balkrishna Kulkarni (Alfa Biomed India Private Limited), Sahadot Ali Mir (Alfa Biomed India Private Limited), among others.